The contrasting effects of METTL3 and METTL14 on CRC progression despite their complex formation and catalytic enhancement may be attributed to their preference for different targets, leading to diverse downstream pathways.8, 71. The gene discussed is METTL3; the disease is colorectal carcinoma.